Top > News Releases

News Releases

Printer Friendly Version

CONTACT : Reiko Sato
Y's Therapeutics Co., Ltd.
+011 81 3 5784-2762
media.relations@ysthera.com

Y's Therapeutics Appoints Nobuo Kato as President and CEO, and
Motoharu Higashizono as Board of Director and COO on Dec 22, 2005.


Nobuo Kato (President & CEO)
1966     Faculty of Pharmaceutical Science, University of Tokyo
1966     Ajinomoto Co.,Inc.
1970     Ajinomoto Co.,Inc. Central Research Laboratories, Life Science Laboratories
1997     General Manager of Department of Clinical Development, Ajinomoto Co.,Inc.
1999     President, Ajinomoto Pharmaceuticals Europe (concurrently)
2001     President, Ajinomoto Pharmaceuticals Europe
2003     Research and Technical Consultant for Pharmaceutical Companies,
              Ajinomoto Co.,Inc.
2005     President & CEO, Y's Therapeutics Co., Ltd. (current position)

Motoharu Higashizono (COO)
1967     BA in Agriculture Engineering in Mechanical Engineering, Nippon University
1967     Isuzu Motors Limited
1981     General Manager of Product Planning Overseas, Isuzu Motors Limited
1991     General Manager of Quality Assurance Dept., Isuzu Motors Limited
1997     CV Engineering and Product Planning Vice President of Detroit USA,
              Isuzu Motors America Inc.
2002     Executive Director of Marktech Co.,Ltd
2004     President, LOGICO-NET corporation (current position)
2005     COO, Y's Therapeutics Co.,Ltd (current position)



PAGE TOP

Top  |  Site Map  |  Access Map  |  Privacy Policy  |  Terms of Use

Top
News Releases
About Us
Pipeline
Project Overview
Partnering Opportunities
Careers
Contact Us
SELECT Y's Therapeutics Y's Therapeutics